Daniel Arias
Stock Analyst at Stifel
(5.00)
# 6
Out of 5,124 analysts
162
Total ratings
60.22%
Success rate
146.25%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLLN BillionToOne | Initiates: Buy | $145 | $81.84 | +77.17% | 1 | Dec 1, 2025 | |
| EXAS Exact Sciences | Downgrades: Hold | $80 → $105 | $101.56 | +3.39% | 8 | Nov 28, 2025 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,450 → $1,600 | $1,394.19 | +14.76% | 8 | Nov 10, 2025 | |
| GH Guardant Health | Maintains: Buy | $60 → $70 | $102.14 | -31.47% | 4 | Sep 25, 2025 | |
| BRKR Bruker | Maintains: Hold | $48 → $40 | $47.11 | -15.09% | 9 | Aug 5, 2025 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $11.46 | +4.71% | 10 | Aug 4, 2025 | |
| RVTY Revvity | Maintains: Hold | $120 → $110 | $96.75 | +13.70% | 2 | Jul 29, 2025 | |
| TECH Bio-Techne | Maintains: Hold | $75 → $60 | $58.81 | +2.02% | 11 | May 8, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $665 → $620 | $579.45 | +7.00% | 16 | Apr 24, 2025 | |
| DHR Danaher | Upgrades: Buy | $260 | $228.92 | +13.58% | 10 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $9 | $1.55 | +480.65% | 2 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $18 | $16.31 | +10.36% | 6 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $6 | $5.25 | +14.29% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $59.05 | +10.08% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $379.83 | -5.22% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $136.07 | +10.97% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $57 → $46 | $44.97 | +3.07% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $3.25 | +207.69% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $163.86 | +26.33% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $131.16 | +52.49% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $1.63 | +206.75% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $3.49 | +186.53% | 2 | May 31, 2022 |
BillionToOne
Dec 1, 2025
Initiates: Buy
Price Target: $145
Current: $81.84
Upside: +77.17%
Exact Sciences
Nov 28, 2025
Downgrades: Hold
Price Target: $80 → $105
Current: $101.56
Upside: +3.39%
Mettler-Toledo International
Nov 10, 2025
Maintains: Buy
Price Target: $1,450 → $1,600
Current: $1,394.19
Upside: +14.76%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $60 → $70
Current: $102.14
Upside: -31.47%
Bruker
Aug 5, 2025
Maintains: Hold
Price Target: $48 → $40
Current: $47.11
Upside: -15.09%
Avantor
Aug 4, 2025
Maintains: Hold
Price Target: $14 → $12
Current: $11.46
Upside: +4.71%
Revvity
Jul 29, 2025
Maintains: Hold
Price Target: $120 → $110
Current: $96.75
Upside: +13.70%
Bio-Techne
May 8, 2025
Maintains: Hold
Price Target: $75 → $60
Current: $58.81
Upside: +2.02%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $665 → $620
Current: $579.45
Upside: +7.00%
Danaher
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $228.92
Upside: +13.58%
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $1.55
Upside: +480.65%
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $16.31
Upside: +10.36%
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $5.25
Upside: +14.29%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $59.05
Upside: +10.08%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $379.83
Upside: -5.22%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $136.07
Upside: +10.97%
May 1, 2024
Maintains: Hold
Price Target: $57 → $46
Current: $44.97
Upside: +3.07%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $3.25
Upside: +207.69%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $163.86
Upside: +26.33%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $131.16
Upside: +52.49%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $1.63
Upside: +206.75%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $3.49
Upside: +186.53%